CVE:ACST

Acasti Pharma Inc. (ACST.V) Competitors

C$0.68
-0.01 (-1.45 %)
(As of 04/9/2021 03:59 PM ET)
Add
Compare
Today's Range
C$0.66
Now: C$0.68
C$0.71
50-Day Range
C$0.67
MA: C$0.86
C$1.19
52-Week Range
C$0.22
Now: C$0.68
C$1.55
Volume86,617 shs
Average Volume725,720 shs
Market CapitalizationC$136.08 million
P/E Ratio20.00
Dividend YieldN/A
BetaN/A

Competitors

Acasti Pharma Inc. (ACST.V) (CVE:ACST) Vs. PLI, NEPT, MDNA, ONC, EMC, and IMV

Should you be buying ACST stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Acasti Pharma Inc. (ACST.V), including ProMetic Life Sciences (PLI), Neptune Wellness Solutions (NEPT), Medicenna Therapeutics (MDNA), Oncolytics Biotech (ONC), Emblem (EMC), and IMV (IMV).

Acasti Pharma Inc. (ACST.V) (CVE:ACST) and ProMetic Life Sciences (TSE:PLI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Valuation & Earnings

This table compares Acasti Pharma Inc. (ACST.V) and ProMetic Life Sciences' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acasti Pharma Inc. (ACST.V)C$81,000.001,680.02C$6.80 millionC$0.0320.00
ProMetic Life SciencesC$39.91 million7.94C$-1,470,117,780.00C($63.06)-0.22

Acasti Pharma Inc. (ACST.V) has higher earnings, but lower revenue than ProMetic Life Sciences. ProMetic Life Sciences is trading at a lower price-to-earnings ratio than Acasti Pharma Inc. (ACST.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Acasti Pharma Inc. (ACST.V) and ProMetic Life Sciences, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acasti Pharma Inc. (ACST.V)0000N/A
ProMetic Life Sciences0000N/A

Profitability

This table compares Acasti Pharma Inc. (ACST.V) and ProMetic Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Acasti Pharma Inc. (ACST.V)N/AN/AN/A
ProMetic Life SciencesN/AN/AN/A

Summary

Acasti Pharma Inc. (ACST.V) beats ProMetic Life Sciences on 4 of the 5 factors compared between the two stocks.

Acasti Pharma Inc. (ACST.V) (CVE:ACST) and Neptune Wellness Solutions (TSE:NEPT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Valuation & Earnings

This table compares Acasti Pharma Inc. (ACST.V) and Neptune Wellness Solutions' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acasti Pharma Inc. (ACST.V)C$81,000.001,680.02C$6.80 millionC$0.0320.00
Neptune Wellness SolutionsC$52.78 million5.55C$-223,415,550.00C($1.35)-1.31

Acasti Pharma Inc. (ACST.V) has higher earnings, but lower revenue than Neptune Wellness Solutions. Neptune Wellness Solutions is trading at a lower price-to-earnings ratio than Acasti Pharma Inc. (ACST.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Acasti Pharma Inc. (ACST.V) and Neptune Wellness Solutions, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acasti Pharma Inc. (ACST.V)0000N/A
Neptune Wellness Solutions00103.00

Neptune Wellness Solutions has a consensus price target of C$4.63, indicating a potential upside of 161.30%. Given Neptune Wellness Solutions' higher possible upside, analysts clearly believe Neptune Wellness Solutions is more favorable than Acasti Pharma Inc. (ACST.V).

Profitability

This table compares Acasti Pharma Inc. (ACST.V) and Neptune Wellness Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Acasti Pharma Inc. (ACST.V)N/AN/AN/A
Neptune Wellness SolutionsN/AN/AN/A

Summary

Acasti Pharma Inc. (ACST.V) beats Neptune Wellness Solutions on 4 of the 7 factors compared between the two stocks.

Acasti Pharma Inc. (ACST.V) (CVE:ACST) and Medicenna Therapeutics (TSE:MDNA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.

Profitability

This table compares Acasti Pharma Inc. (ACST.V) and Medicenna Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Acasti Pharma Inc. (ACST.V)N/AN/AN/A
Medicenna TherapeuticsN/AN/AN/A

Valuation and Earnings

This table compares Acasti Pharma Inc. (ACST.V) and Medicenna Therapeutics' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acasti Pharma Inc. (ACST.V)C$81,000.001,680.02C$6.80 millionC$0.0320.00
Medicenna TherapeuticsN/AN/AN/AC($0.31)-16.44

Acasti Pharma Inc. (ACST.V) has higher revenue and earnings than Medicenna Therapeutics. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than Acasti Pharma Inc. (ACST.V), indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent recommendations for Acasti Pharma Inc. (ACST.V) and Medicenna Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acasti Pharma Inc. (ACST.V)0000N/A
Medicenna Therapeutics0000N/A

Summary

Acasti Pharma Inc. (ACST.V) beats Medicenna Therapeutics on 3 of the 3 factors compared between the two stocks.

Acasti Pharma Inc. (ACST.V) (CVE:ACST) and Oncolytics Biotech (TSE:ONC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation.

Profitability

This table compares Acasti Pharma Inc. (ACST.V) and Oncolytics Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Acasti Pharma Inc. (ACST.V)N/AN/AN/A
Oncolytics BiotechN/AN/AN/A

Earnings & Valuation

This table compares Acasti Pharma Inc. (ACST.V) and Oncolytics Biotech's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acasti Pharma Inc. (ACST.V)C$81,000.001,680.02C$6.80 millionC$0.0320.00
Oncolytics BiotechN/AN/AN/AC($0.56)-8.91

Acasti Pharma Inc. (ACST.V) has higher revenue and earnings than Oncolytics Biotech. Oncolytics Biotech is trading at a lower price-to-earnings ratio than Acasti Pharma Inc. (ACST.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings for Acasti Pharma Inc. (ACST.V) and Oncolytics Biotech, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acasti Pharma Inc. (ACST.V)0000N/A
Oncolytics Biotech01202.67

Oncolytics Biotech has a consensus target price of C$6.00, indicating a potential upside of 20.24%. Given Oncolytics Biotech's higher possible upside, analysts clearly believe Oncolytics Biotech is more favorable than Acasti Pharma Inc. (ACST.V).

Summary

Acasti Pharma Inc. (ACST.V) beats Oncolytics Biotech on 3 of the 5 factors compared between the two stocks.

Emblem (CVE:EMC) and Acasti Pharma Inc. (ACST.V) (CVE:ACST) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for Emblem and Acasti Pharma Inc. (ACST.V), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Emblem0000N/A
Acasti Pharma Inc. (ACST.V)0000N/A

Valuation and Earnings

This table compares Emblem and Acasti Pharma Inc. (ACST.V)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Emblem$5.71 million43.02C$-24,806,020.00($0.19)-9.89
Acasti Pharma Inc. (ACST.V)C$81,000.001,680.02C$6.80 millionC$0.0320.00

Acasti Pharma Inc. (ACST.V) has lower revenue, but higher earnings than Emblem. Emblem is trading at a lower price-to-earnings ratio than Acasti Pharma Inc. (ACST.V), indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Emblem and Acasti Pharma Inc. (ACST.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
EmblemN/AN/AN/A
Acasti Pharma Inc. (ACST.V)N/AN/AN/A

Summary

Acasti Pharma Inc. (ACST.V) beats Emblem on 4 of the 5 factors compared between the two stocks.

Acasti Pharma Inc. (ACST.V) (CVE:ACST) and IMV (TSE:IMV) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Earnings & Valuation

This table compares Acasti Pharma Inc. (ACST.V) and IMV's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acasti Pharma Inc. (ACST.V)C$81,000.001,680.02C$6.80 millionC$0.0320.00
IMVC$3,000.0081,704.61C$-39,136,958.00C($0.58)-6.26

Acasti Pharma Inc. (ACST.V) has higher revenue and earnings than IMV. IMV is trading at a lower price-to-earnings ratio than Acasti Pharma Inc. (ACST.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and price targets for Acasti Pharma Inc. (ACST.V) and IMV, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acasti Pharma Inc. (ACST.V)0000N/A
IMV04002.00

IMV has a consensus price target of C$5.08, suggesting a potential upside of 40.42%. Given IMV's higher probable upside, analysts plainly believe IMV is more favorable than Acasti Pharma Inc. (ACST.V).

Profitability

This table compares Acasti Pharma Inc. (ACST.V) and IMV's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Acasti Pharma Inc. (ACST.V)N/AN/AN/A
IMVN/AN/AN/A

Summary

Acasti Pharma Inc. (ACST.V) beats IMV on 4 of the 6 factors compared between the two stocks.


Acasti Pharma Inc. (ACST.V) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ProMetic Life Sciences logo
PLI
ProMetic Life Sciences
0.5$13.60-0.2%C$315.66 millionC$39.91 million-0.22
NEPT
Neptune Wellness Solutions
1.2$1.77-4.0%C$292.92 millionC$52.78 million-1.31
MDNA
Medicenna Therapeutics
0.5$5.08-0.8%C$268.74 millionN/A-16.44
ONC
Oncolytics Biotech
1.0$4.99-16.2%C$259.90 millionN/A-8.91
EMC
Emblem
0.5$1.88-1.6%$248.31 million$5.71 million-9.89
IMV logo
IMV
IMV
1.2$3.62-0.6%C$245.11 millionC$3,000.00-6.26
ATE
Antibe Therapeutics
1.3$4.88-1.0%C$222.07 millionC$9.33 million-6.20
FRX
Fennec Pharmaceuticals
0.5$7.82-6.5%C$203.34 millionC$170,000.00-10.24Gap Up
RVX
Resverlogix
0.7$0.86-0.0%C$202.07 millionN/A78.18Upcoming Earnings
HBP
Helix BioPharma
0.5$0.92-1.1%C$129.84 millionN/A-16.73
IPA
ImmunoPrecise Antibodies
0.4$15.41-4.9%C$123.03 millionC$17.18 million-72.01Gap Up
NVH
Novoheart
0.5$0.53-1.9%C$79.23 millionC$423,500.00-13.95
PMN
ProMIS Neurosciences
0.5$0.22-0.0%C$67.31 millionC$1,787.00-11.00
PDP
Pediapharm
0.5$0.30-1.7%C$66.36 millionC$11.16 million-4.11
MBX
Microbix Biosystems
0.9$0.55-3.6%C$60.20 millionC$11.64 million-10.78
SBM
Sirona Biochem
0.5$0.38-1.3%C$58.80 millionC$123,870.00-29.23
COV
Covalon Technologies
0.6$1.41-0.7%C$37.44 millionC$23.84 million-5.92
Emerald Health Therapeutics logo
EMH
Emerald Health Therapeutics
0.5$0.29-1.7%C$34.02 millionC$13.02 million-0.42
IGX
IntelGenx Technologies
0.9$0.57-3.5%C$30.87 millionC$1.54 million-8.77
QPT
Quest PharmaTech
0.8$0.11-9.1%C$21.76 millionC$38,871.000.17High Trading Volume
CZO
Ceapro
0.7$0.72-4.2%C$21.65 millionC$16.14 million21.82
CTX
Crescita Therapeutics
0.6$0.86-2.3%C$17.76 millionC$15.64 million430.00Gap Up
KNE
Kane Biotech
0.4$0.17-0.0%C$14.12 millionC$1.34 million-4.86
GSD
Devonian Health Group
0.5$0.27-3.7%C$13.96 millionC$1.59 million-5.63Gap Up
PAS
Pascal Biosciences
0.6$0.09-5.6%C$12.70 millionN/A-4.09
NSP
Naturally Splendid Enterprises
0.6$0.06-0.0%C$11.06 millionC$2.03 million-1.40Gap Down
MPH
Medicure
0.7$1.60-5.0%C$10.80 millionC$12.71 million-1.03Gap Down
BTI
Bioasis Technologies
0.7$0.39-3.8%C$10.16 millionC$4.12 million35.45
HEM
Hemostemix
0.6$0.49-1.0%C$9.07 millionN/A-2.92Gap Down
ICO
iCo Therapeutics
0.5$0.11-0.0%C$7.69 millionN/A-8.75News Coverage
IBT
IBEX Technologies
0.7$0.36-1.4%C$6.94 millionC$5.60 million6.57Gap Down
IOT
Innovotech
0.8$0.15-3.3%C$6.52 millionC$1.04 million75.00
BCT
BriaCell Therapeutics
0.5$6.40-15.3%C$4.48 millionN/A-2.07High Trading Volume
Gap Down
RVV
Revive Therapeutics
0.5$0.08-12.5%C$3.62 millionN/A-3.64High Trading Volume
Gap Down
COT
Cotinga Pharmaceuticals Inc. (COT.V)
0.5$0.04-71.4%C$1.54 millionN/A-0.30Upcoming Earnings
Gap Up
PBS
Pacgen Life Science Co. (PBS.V)
0.6$0.03-16.7%C$1.30 millionC$302,079.00-5.00Gap Down
MFS
Medifocus Inc. (MFS.V)
0.5$0.01-0.0%C$925,000.00C$2.23 million-1.00
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
COM
138267 (COM.TO)
0.5$2.95-2.7%C$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
HALO
Halozyme Therapeutics
1.7$42.77-1.3%C$0.00C$267.59 million47.00
LTY
Liberty Biopharma
0.6$2.00-100.0%C$0.00N/A-12.66Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
News Coverage
SCYB
Scythian Biosciences
0.5$3.49-6.3%C$0.00N/A0.00High Trading Volume
ABCN
VIVO Cannabis
0.6$1.32-5.3%C$0.00N/A0.00Gap Down
VP
Vodis Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.